Predict your next investment

Vascular Dynamics company logo
HEALTHCARE | Medical Devices & Equipment / Surgical Devices
vasculardynamics.com

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$65.07M

Last Raised

$33.05M | 1 yr ago

About Vascular Dynamics

Vascular Dynamics develops a small implant, placed in the carotid artery, for the treatment of hypertension (high blood pressure). Vascular Dynamic is a fully owned Rainbow Medical company.

Vascular Dynamics Headquarter Location

2134 Old Middlefield Way #J

Mountain View, California, 94043,

United States

650-963-9370

Latest Vascular Dynamics News

Vascular Dynamics’ Early Clinical Results for Novel Heart Failure Treatment Show Promise as Stan Rabinovich is Named to Board of Directors

May 18, 2021

May 18, 2021 12:03 PM Eastern Daylight Time IRVINE, Calif.--( BUSINESS WIRE )-- Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from cardiovascular conditions, has announced that encouraging early results for its heart failure clinical trial have been presented. The company has also announced the addition of Stan Rabinovich to its Board of Directors. At this week’s EuroPCR meeting, data from VDI’s clinical trial, “A Feasibility Study Exploring the Effect of the MobiusHD® Device in Patients with Heart Failure” were reported. An endovascular approach is used to implant VDI’s MobiusHD device, targeting baroreceptor sensory neurons which respond to stretching and are located along the carotid arteries in the neck. The MobiusHD device is designed to amplify the natural baroreflex mechanism signaling the brain to produce therapeutic modulation of the autonomic nervous system. An autonomic nervous system imbalance is an underlying pathogenesis of heart failure. Horst Sievert, MD, Director of the CardioVascular Center in Frankfurt, reported that 19 heart failure patients with reduced ejection fraction (HFrEF) were safely and successfully treated using the endovascular procedure with the MobiusHD device. Three-month data for these patients were presented, and all 19 patients demonstrated impressive, clinically meaningful improvement. Statistically significant improvements at three-months compared to baseline in Kansas City Cardiomyopathy Questionnaire scores, six-minute hallway walk distances, NT-proBNP levels, and left ventricular echocardiography parameters were reported. "These initial clinical results have shown impressive efficacy and demonstrated that the MobiusHD device provides a safe option to treat heart failure patients," said Dr. Sievert. "We have more work to do to establish longer-term efficacy, but these data are further evidence that placing the MobiusHD device in the carotid artery can be done safely." VDI plans to continue treating appropriate heart failure patients at centers around the world while engaging the FDA to define the parameters for a pivotal IDE clinical trial in the US. The report of the clinical trial results is accompanied by news that Stan Rabinovich has joined the VDI Board of Directors. Rabinovich has a remarkable track record in the development and commercialization of disruptive innovations. He brings to VDI a unique perspective based on his extensive endovascular device expertise spanning 40 years. His pioneering efforts include the development of coronary stents, drug-eluting stents, and transcatheter heart valves. He was a co-founder of Percutaneous Valve Technologies, Inc. (PVT) which was subsequently acquired in 2004 by Edwards Lifesciences. While at Edwards, he was focused on technologies, applications, and business alliances related to structural heart disease as Vice President of Advanced Technology and Discovery. In 2018, Rabinovich received the Innovator Award at the 25th Annual Phoenix Medical Device Conference. “We are thrilled to have Stan join our team,” said Ed Roschak, VDI’s CEO. “His engagement with us is particularly well timed as we continue to gather encouraging early clinical results from our feasibility study in heart failure patients. We are expanding our efforts to clinical centers around the world. Additional results will be reported as they become available.” About Vascular Dynamics, Inc. Vascular Dynamics develops innovative, endovascular platform technologies to offer compelling treatment options for patients at risk of life-threatening conditions underserved by conventional treatments. The company’s MobiusHD technology features the first endovascular device to use the body’s natural baroreflex mechanism to modulate the autonomic nervous system and help restore sympathetic balance. Clinical evaluations are in progress. More information is available at www.vasculardynamics.com . Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Vascular Dynamics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vascular Dynamics is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,528 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

Vascular Dynamics Patents

Vascular Dynamics has filed 14 patents.

The 3 most popular patent topics include:

  • Angiology
  • Implants (medicine)
  • Vascular diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2015

9/29/2020

Cardiovascular physiology, Cardiology, Cardiac anatomy, Vascular diseases, Implants (medicine)

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/23/2015

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/29/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Cardiovascular physiology, Cardiology, Cardiac anatomy, Vascular diseases, Implants (medicine)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Vascular Dynamics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vascular Dynamics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.